An American physician and medical researcher whose inactivated polio vaccine turned one of the twentieth century's most feared epidemics into a preventable disease. Working at the University of Pittsburgh, he developed the vaccine tested in the 1954 national field trial on one million children aged six to nine, remembered as the Polio Pioneers, among the largest public health experiments ever run. On April 12, 1955 the results were announced: the vaccine was safe and effective, and mass vaccination followed across the United States and the world. Salk's decision not to patent the vaccine made him an enduring emblem of public health as a public good, and he founded the Salk Institute for Biological Studies in La Jolla in 1960, working there until his death in 1995.
Facts
Notable ForDeveloping the first widely used inactivated polio vaccine, proven safe and effective in the landmark 1954 national field trial on one million children. 1 Connections
In Branch
Source Salk Institute Website
Milestones Credited
Source Salk Institute Website
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Sources
1. Salk Institute Website
Salk Institute for Biological StudiesAbout Jonas Salk biography, 1954 trial
In 1954, national testing began on one million children, ages six to nine, who became known as the Polio Pioneers
About Jonas Salk biography, 1955 announcement
On April 12, 1955, the results were announced: the vaccine was safe and effective
About Jonas Salk biography, birth
Jonas Edward Salk was born October 28, 1914 in New York City
About Jonas Salk biography, death
Salk died on June 23, 1995 at the age of 80 in La Jolla, California
- In Branch: Public Health, About Jonas Salk biography, public health legacy
Milestones Credited: Launch of Mass Polio Vaccination, About Jonas Salk biography, 1954 launch
In 1954, national testing began on one million children, ages six to nine, who became known as the Polio Pioneers
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.